Dare Bioscience Inc (DARE)
0.4351
-0.01
(-1.78%)
USD |
NASDAQ |
Jun 25, 16:00
0.4351
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Accounts Payable (Quarterly): 4.040M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.040M |
December 31, 2023 | 3.386M |
September 30, 2023 | 4.987M |
June 30, 2023 | 6.541M |
March 31, 2023 | 2.696M |
December 31, 2022 | 2.028M |
September 30, 2022 | 3.477M |
June 30, 2022 | 1.114M |
March 31, 2022 | 2.831M |
December 31, 2021 | 2.103M |
September 30, 2021 | 0.6057M |
June 30, 2021 | 0.216M |
March 31, 2021 | 1.472M |
December 31, 2020 | 1.021M |
September 30, 2020 | 1.555M |
June 30, 2020 | 1.714M |
March 31, 2020 | 1.532M |
December 31, 2019 | 1.083M |
September 30, 2019 | 0.3522M |
June 30, 2019 | 0.6321M |
March 31, 2019 | 0.3256M |
Date | Value |
---|---|
December 31, 2018 | 0.4597M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.3082M |
September 30, 2017 | 0.8394M |
June 30, 2017 | 0.66M |
March 31, 2017 | 0.644M |
December 31, 2016 | 0.00 |
September 30, 2016 | 1.778M |
June 30, 2016 | 1.593M |
March 31, 2016 | 2.19M |
December 31, 2015 | 2.226M |
September 30, 2015 | 2.158M |
June 30, 2015 | 1.808M |
March 31, 2015 | 1.682M |
December 31, 2014 | 1.255M |
September 30, 2014 | 1.461M |
June 30, 2014 | 0.579M |
March 31, 2014 | 2.16M |
December 31, 2013 | 0.914M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.216M
Minimum
Jun 2021
6.541M
Maximum
Jun 2023
2.169M
Average
1.635M
Median
Accounts Payable (Quarterly) Benchmarks
Altimmune Inc | 3.76M |
Verastem Inc | 7.449M |
Oragenics Inc | 0.6958M |
Actinium Pharmaceuticals Inc | -- |
Orgenesis Inc | 16.40M |